<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">Arq. Bras. Cardiol.</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24676373</article-id><article-id pub-id-type="pmc">3987333</article-id><article-id pub-id-type="doi">10.5935/abc.20140006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Acute Effects of Continuous Positive Air way Pressure on Pulse Pressure
in Chronic Heart Failure</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Quint&#x000e3;o</surname><given-names>M&#x000f4;nica</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Chermont</surname><given-names>S&#x000e9;rgio</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>Marchese</surname><given-names>Luana</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Brand&#x000e3;o</surname><given-names>L&#x000fa;cia</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Bernardez</surname><given-names>Sabrina Pereira</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Mesquita</surname><given-names>Evandro Tinoco</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>Nazareth de Novaes</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>N&#x000f3;brega</surname><given-names>Ant&#x000f4;nio Claudio L.</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label> Programa de P&#x000f3;s-gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias Cardiovasculares/Universidade
Federal Fluminense, Teres&#x000f3;polis, RJ - Brazil </aff><aff id="aff02"><label>2</label> Cl&#x000ed;nica de Insufici&#x000ea;ncia Card&#x000ed;aca (CLIC)/Centro Universit&#x000e1;rio Serra dos
&#x000d3;rg&#x000e3;os, Teres&#x000f3;polis, RJ - Brazil </aff><author-notes><corresp id="c01"><bold>Mailing Address: Sergio Chermont,</bold> Estrada da Prata s/n. Prata. CEP
25976-340, Teres&#x000f3;polis, RJ - Brazil. E-mail: <email>schermont@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2014</year></pub-date><volume>102</volume><issue>2</issue><fpage>181</fpage><lpage>186</lpage><history><date date-type="received"><day>08</day><month>6</month><year>2013</year></date><date date-type="rev-recd"><day>10</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p></license></permissions><abstract><sec><title>Background</title><p> Patients with heart failure (HF) have left ventricular dysfunction and reduced
mean arterial pressure (MAP). Increased adrenergic drive causes vasoconstriction
and vessel resistance maintaining MAP, while increasing peripheral vascular
resistance and conduit vessel stiffness. Increased pulse pressure (PP) reflects a
complex interaction of the heart with the arterial and venous systems. Increased
PP is an important risk marker in patients with chronic HF (CHF). Non-invasive
ventilation (NIV) has been used for acute decompensated HF, to improve congestion
and ventilation through both respiratory and hemodynamic effects. However, none of
these studies have reported the effect of NIV on PP. </p></sec><sec><title>Objective</title><p>The objective of this study was to determine the acute effects of NIV with CPAP on
PP in outpatients with CHF. </p></sec><sec><title>Methods</title><p>Following a double-blind, randomized, cross-over, and placebo-controlled protocol,
twenty three patients with CHF (17 males; 60 &#x000b1; 11 years; BMI 29 &#x000b1; 5
kg/cm<sup>2</sup>, NYHA class II, III) underwent CPAP via nasal mask for 30 min
in a recumbent position. Mask pressure was 6 cmH<sub>2</sub>O, whereas placebo was
fixed at 0-1 cmH<sub>2</sub>O. PP and other non invasive hemodynamics variables
were assessed before, during and after placebo and CPAP mode. </p></sec><sec><title>Results</title><p>CPAP decreased resting heart rate (Pre: 72 &#x000b1; 9; vs. Post 5 min: 67 &#x000b1; 10 bpm; p
&#x0003c; 0.01) and MAP (CPAP: 87 &#x000b1; 11; vs. control 96 &#x000b1; 11 mmHg; p &#x0003c; 0.05 post 5
min). CPAP decreased PP (CPAP: 47 &#x000b1; 20 pre to 38 &#x000b1; 19 mmHg post; vs. control: 42 &#x000b1;
12 mmHg, pre to 41 &#x000b1; 18 post p &#x0003c; 0.05 post 5 min). </p></sec><sec><title>Conclusion</title><p> NIV with CPAP decreased pulse pressure in patients with stable CHF. Future
clinical trials should investigate whether this effect is associated with improved
clinical outcome.</p></sec></abstract><kwd-group><kwd>Heart Failure</kwd><kwd>Pulse Pressure</kwd><kwd>CPAP</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Heart failure (HF) is one of the main public burdens in developing countries, and
despite medical advances, the mortality of HF remains elevated <sup><xref rid="r01" ref-type="bibr">1</xref></sup>. Neurohumoral activation in HF leads to
left ventricular dysfunction and reduced mean arterial pressure (MAP). Compensatory
mechanisms to maintain MAP causes vasoconstriction, which increases peripheral vascular
resistance and conduit vessel stiffness <sup><xref rid="r02" ref-type="bibr">2</xref></sup>. These effects increase pulse pressure (PP), which reflects a complex
interaction of the heart with the arterial and venous systems <sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup>. Pulse pressure
is determined by two hemodynamic components: a direct component, which is a product of
ventricular ejection (stroke volume and ventricular ejection swiftness) and great vessel
viscoelastic property interactions, as well as an indirect component resulting from the
pulse wave <sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup>. As increased PP expresses progression of HF, it is has been
related to increased ventricular afterload <sup><xref rid="r07" ref-type="bibr">7</xref></sup> and myocardial oxygen demand <sup><xref rid="r08" ref-type="bibr">8</xref></sup>, impaired ventricular relaxation <sup><xref rid="r09" ref-type="bibr">9</xref></sup>, and subendocardial ischemia <sup><xref rid="r10" ref-type="bibr">10</xref></sup>. Therefore, increased PP is an important risk marker for
subsequent cardiovascular events in patients with chronic HF (CHF)<sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>. Previous studies have reported that a PP of 50 mm Hg is the mean
normal value for clinic reference &#x0200b;&#x0200b;in both men and women<sup><xref rid="r13" ref-type="bibr">13</xref></sup>, and above 53 mm Hg it increases risk of cardiovascular
events <sup><xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup>.</p><p>Noninvasive ventilation (NIV) has been used in decompensated HF to decrease pulmonary
congestion and improve ventilation through both mechanical and hemodynamic effects
<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref></sup>. In patients with stable CHF, NIV has not been extensively
studied. Naughton et al <sup><xref rid="r18" ref-type="bibr">18</xref></sup> have shown
that the administration of continuous positive airway pressure (CPAP) to patients with
stable HF at rest acutely improved cardiac performance and also reduced the work of
breathing. Others have shown increases in cardiac output and stroke volume along with
decreased systemic vascular resistance among patients with CHF and elevated left
ventricular filling pressure <sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup>. However, none of these studies has
reported the effect of NIV on PP, which is an independent risk marker in patients with
stable HF <sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>. </p><p>In the present study, we hypothesized that in patients with CHF, NIV would decrease
pulse pressure by unloading the ventilatory muscles and improving cardiac performance.
Therefore, the aim of the present study was to determine the effects of a single session
of NIV with CPAP on pulse pressure in patients with stable CHF.</p></sec><sec sec-type="methods"><title>Methods</title><p>The study included patients with systolic CHF from the University Hospital Heart Failure
Clinics. The inclusion criteria were: 1) CHF of either ischemic or idiopathic etiology
for at least 3 months, 2) left ventricular ejection fraction (LVEF) &#x02264; 45% within the
previous 3 months, documented by echocardiography or radioisotope ventriculography, 3)
New York Heart Association class II or III; 4) stable disease with no hospital admission
in the previous 3 months. Clinical stability was defined as the absence of change in
symptoms, clinical status, or medications in the preceding 3 months. Patients were
excluded from the study if they had significant obstructive lung disease
(FEV<sub>1</sub>/FVC &#x0003c; 75% predicted), unstable angina, significant cardiac
arrhythmias, or myocardial infarction within the previous 3 months. The subjects
completed a screening visit that included a clinical examination and pulmonary function
testing (Marquette Hellige, Germany). This protocol was approved by the Human Research
Ethics Committee and all patients gave informed consent before entering the study. </p><p>The study protocol consisted of a double-blind, randomized, cross-over, and
placebo-controlled investigation of the hemodynamic effects of NIV in a controlled
environment. Twenty-three patients were recruited and the experiments were performed on
two different days with an interval of 3-5 days. The patient had no knowledge of prior
randomized ventilation mode and the principal investigator was not present at the scene
of NIV. A preliminary NIV session was performed for adaptation and determination of mask
size, tolerance to the method and the individual pressure of CPAP to be used in the
experiment. The sensation of respiratory discomfort was gauged during all tests by using
an arbitrary comfort score (0 = no discomfort, up to 5 = very uncomfortable). This
parameter was used to limit the increase or to decrease mask pressure whenever the
rating reached 4 or 5 in the NIV adaptation sessions.</p><p>On CPAP day, patients underwent a protocol using the predetermined mask pressure and
CPAP time. On the control day, patients underwent placebo CPAP consisting of the
application of a fixed pressure of &#x02264; 1 cmH<sub>2</sub>O for 30 min by means of a bypass
valve (<xref ref-type="fig" rid="f01">Figure 1</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart of the study design. CHF: chronic heart failure; NIV: non-invasive
ventilation; CPAP: continuous positive airway pressure.</p></caption><graphic xlink:href="abc-102-02-0181-g01"/></fig><p>NIV in the CPAP mode (Tranquility, Healthdyne, USA), was applied via nasal mask
(Sealflex, Caradyne, USA) for 30 min in the recumbent position, preceded by a resting
steady state period of 15 min of spontaneous breathing. Mask pressure was initially set
to 3 cmH<sub>2</sub>O for 5 min followed to 6 cmH<sub>2</sub>O, according to each
patient's predetermined tolerance.</p><p>During NIV, heart rate (HR) and oxygen saturation (SpO<sub>2</sub>) by pulse oximetry
(Healthdyne, Marietta, GA) were continuously monitored, and blood pressure (BP) was
measured manually at the end of the resting period and at 5, 10, 20, and 30 min of NIV
(auscultatory method obtained by trained researcher using a standard mercury
sphygmomanometer on the left arm). Respiratory rate (RR) and SpO<sub>2 </sub>were
recorded, at these same intervals. In order to test whether the effect of CPAP persisted
after cessation of NIV, the hemodynamic variables were measured 5 min after
discontinuation of NIV (post). </p><sec><title>Statistical Analysis</title><p>All data were assessed by the Kolmogorov-Smirnov test to determine whether they
followed normal distribution. Temporal changes in hemodynamic and respiratory
variables (randomized, placebo controlled experiment) were compared during NIV and
placebo by two-way ANOVA with repeated measures, where ventilatory mode (NIV or
placebo) and time were the main variables. When F values were significant, pairwise
comparisons were performed with the Bonferroni post-hoc test. The number of subjects
to be studied was calculated from the PP response obtained from previous studies,
where the minimal detectable difference in means was 7 mmHg and the expected standard
deviation of residuals was 5 mmHg. For this expected size effect and deviation and
establishing the statistical power at 0.8 and alpha error at 0.05, the minimum sample
size was determined to be of at least 9 subjects. All results are expressed as means
&#x000b1; SEM and p &#x0003c; 0.05 was considered significant.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Forty patients were invited to take part in the study and twenty-three of them agreed to
participate and were effectively enrolled in the present study. The characteristics of
the subjects are shown in <xref ref-type="table" rid="t01">Table 1</xref>. </p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristic of heart failure patients participating in the study</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Sample size</bold>
</th><th rowspan="1" colspan="1">
<bold>23 (17M / 6F)</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> Age (years)</td><td align="center" rowspan="1" colspan="1"> 60 &#x000b1; 10</td></tr><tr><td rowspan="1" colspan="1"> Weight (kg)</td><td align="center" rowspan="1" colspan="1"> 78 &#x000b1; 18</td></tr><tr><td rowspan="1" colspan="1"> Height (cm)</td><td align="center" rowspan="1" colspan="1"> 160 &#x000b1; 0,1</td></tr><tr><td rowspan="1" colspan="1"> BMI (kg/cm<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1"> 29 &#x000b1; 6</td></tr><tr><td rowspan="1" colspan="1"> HF Etiology</td><td align="center" rowspan="1" colspan="1"> 12/11</td></tr><tr><td rowspan="1" colspan="1"> NYHA</td><td align="center" rowspan="1" colspan="1"> 13 class II/ 10 class III</td></tr><tr><td colspan="2" rowspan="1">
<bold>Medications</bold>
</td></tr><tr><td rowspan="1" colspan="1"> ACEI</td><td align="center" rowspan="1" colspan="1"> 83%</td></tr><tr><td rowspan="1" colspan="1"> Diuretics</td><td align="center" rowspan="1" colspan="1"> 75%</td></tr><tr><td rowspan="1" colspan="1"> Digoxin</td><td align="center" rowspan="1" colspan="1"> 33%</td></tr><tr><td rowspan="1" colspan="1"> Nitrates</td><td align="center" rowspan="1" colspan="1"> 16%</td></tr><tr><td rowspan="1" colspan="1">&#x003b2;-blockers</td><td align="center" rowspan="1" colspan="1"> 66%</td></tr></tbody></table><table-wrap-foot><fn><p>BMI: body mass index; NYHA: New York Heart Association; M: male; F: female;
ACEI: Angiotensin converting enzyme inhibitors.</p></fn></table-wrap-foot></table-wrap><p>A controlled experiment was added following a randomized, placebo controlled and
cross-over protocol to reduce bias in the analysis of the hemodynamic effects of acute
NIV in patients with CHF. Of the 40 patients, 17 had to be excluded from the study due
to: 1) clinical instability; 2) discomfort with the mask or claustrophobic reactions;
or, 3) unwillingness to participate. Consequently the experiments involved 23 patients,
whose characteristics are depicted in <xref ref-type="table" rid="t01">Table
1</xref>.</p><p>The results showed a decrease in HR, systolic blood pressure (SBP), PP, and RR with NIV
and CPAP when compared to pre-CPAP values (p &#x0003c; 0.05). Values for SBP, diastolic blood
pressure (DBP), and MAP during CPAP were lower than controls (p &#x0003c; 0.05). PP
progressively declined, reaching the lowest value at 20 min post CPAP (p &#x0003c; 0.05). On
the other hand, HR decreased at 5 min of CPAP and remained lower than pre- values until
the end of the analysis (<xref ref-type="table" rid="t02">Table 2</xref>).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Effects of non-invasive ventilation with continuous positive airway pressure or
placebo on hemodynamic variables in heart failure patients (n = 23)</p></caption><table frame="hsides" rules="rows"><thead><tr><th rowspan="1" colspan="1">
<bold>Moment</bold>
</th><th colspan="2" rowspan="1">
<bold>HR</bold>
</th><th colspan="2" rowspan="1">
<bold>SBP</bold>
</th><th colspan="2" rowspan="1">
<bold>DBP</bold>
</th><th colspan="2" rowspan="1">
<bold>MAP</bold>
</th><th colspan="2" rowspan="1">
<bold>PP</bold>
</th><th colspan="2" rowspan="1">
<bold>RR</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1"> CTRL</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1"> CTRL</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1"> CTRL</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1"> CTRL</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1"> CTRL</td><td align="center" rowspan="1" colspan="1"> CPAP</td><td align="center" rowspan="1" colspan="1">
<bold>CTRL</bold>
</td></tr><tr><td rowspan="1" colspan="1"> Pre</td><td align="center" rowspan="1" colspan="1"> 72 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1"> 69 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1"> 117 &#x000b1; 17</td><td align="center" rowspan="1" colspan="1"> 115 &#x000b1; 17</td><td align="center" rowspan="1" colspan="1"> 70 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 73 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 86 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 87 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 47 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1"> 42 &#x000b1; 18</td><td align="center" rowspan="1" colspan="1"> 19 &#x000b1; 4</td><td align="center" rowspan="1" colspan="1"> 20 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1"> 5min</td><td align="center" rowspan="1" colspan="1"> 68 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 69 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1"> 112 &#x000b1; 16<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 118 &#x000b1; 19</td><td align="center" rowspan="1" colspan="1"> 71 &#x000b1; 12<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 75 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 85 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 89 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 41 &#x000b1; 17</td><td align="center" rowspan="1" colspan="1"> 43 &#x000b1; 16</td><td align="center" rowspan="1" colspan="1"> 17 &#x000b1; 3<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 20 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1"> 10min</td><td align="center" rowspan="1" colspan="1"> 67 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 71 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 113 &#x000b1; 17<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 118 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1"> 71 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 75 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1"> 85 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 90 &#x000b1; 13</td><td align="center" rowspan="1" colspan="1"> 42 &#x000b1; 18</td><td align="center" rowspan="1" colspan="1"> 43 &#x000b1; 16</td><td align="center" rowspan="1" colspan="1"> 17 &#x000b1; 3<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 20 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1"> 20min</td><td align="center" rowspan="1" colspan="1"> 68 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 70 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 111 &#x000b1; 17<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 117 &#x000b1; 19</td><td align="center" rowspan="1" colspan="1"> 73 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 75 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1"> 86 &#x000b1; 10&#x02020;</td><td align="center" rowspan="1" colspan="1"> 89 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 38&#x000b1;17<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 42 &#x000b1; 14</td><td align="center" rowspan="1" colspan="1"> 17 &#x000b1; 3<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 19 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1"> 30min</td><td align="center" rowspan="1" colspan="1"> 67 &#x000b1; 11<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 70 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 112 &#x000b1; 16<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 116 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1"> 74 &#x000b1; 9<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 75 &#x000b1; 9</td><td align="center" rowspan="1" colspan="1"> 86 &#x000b1; 9<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 88 &#x000b1; 11</td><td align="center" rowspan="1" colspan="1"> 39&#x000b1;16<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 41 &#x000b1; 16</td><td align="center" rowspan="1" colspan="1"> 18 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1"> 19 &#x000b1; 3</td></tr><tr><td rowspan="1" colspan="1"> Post5min</td><td align="center" rowspan="1" colspan="1"> 67 &#x000b1; 10<xref ref-type="table-fn" rid="t02-fn01">*</xref></td><td align="center" rowspan="1" colspan="1"> 72 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 113 &#x000b1; 18<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 118 &#x000b1; 20</td><td align="center" rowspan="1" colspan="1"> 74 &#x000b1; 10</td><td align="center" rowspan="1" colspan="1"> 77 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 87 &#x000b1; 10<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 90 &#x000b1; 12</td><td align="center" rowspan="1" colspan="1"> 38&#x000b1;19<xref ref-type="table-fn" rid="t02-fn01">*</xref>
<xref ref-type="table-fn" rid="t02-fn02">&#x02020;</xref></td><td align="center" rowspan="1" colspan="1"> 41 &#x000b1; 18</td><td align="center" rowspan="1" colspan="1"> 19 &#x000b1; 3</td><td align="center" rowspan="1" colspan="1"> 19 &#x000b1; 3</td></tr></tbody></table><table-wrap-foot><fn id="t02-fn01"><label>*</label><p> p &#x0003c; 0.05 vs. Pre for the same mode;</p></fn><fn id="t02-fn02"><label>&#x02020;</label><p> p &#x0003c; 0.05 CPAP vs. Placebo at the same moment; CPAP: continuous positive
airway pressure; CTRL: control; HR: heart rate; SBP: systolic blood pressure;
DBP: diastolic blood pressure; MAP: mean arterial pressure; PP: pulse pressure;
RR: respiratory rate.</p></fn></table-wrap-foot></table-wrap><p>The behavior of pulse pressure during and after CPAP mode against placebo, are shown in
<xref ref-type="fig" rid="f02">Figure 2</xref>.</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Pulse pressure (PP), of patients with chronic heart failure (n = 23) measured at
5, 10, 20, and 30 minutes of non-invasive ventilation with continuous positive
airway pressure (CPAP; triangle symbols) or Placebo (circle symbols) * p &#x0003c; 0.01
vs. PRE for the same mode of ventilation; &#x02020; p &#x0003c; 0.001 vs. Placebo at the same
moment.</p></caption><graphic xlink:href="abc-102-02-0181-g02"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>Previous studies evaluated the hemodynamic effects of CPAP in patients with acute HF
<sup><xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref></sup> while others evaluated the clinical relevance of PP <sup><xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref></sup>, but few studies have studied the effects of CPAP in patients with
chronic HF <sup><xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r25" ref-type="bibr">25</xref></sup>. Therefore, it is not surprising that some of the
present findings are similar to previous publications involving patients with
decompensated HF <sup><xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref></sup> and may reflect direct heart-lung interactions leading
to an overall improvement in cardiac performance and decreased respiratory effort
<sup><xref rid="r22" ref-type="bibr">22</xref></sup>. However, the main purpose of
the study was to determine specifically the effects of NIV with CPAP on PP since it is a
useful hemodynamic indicator of conduit artery vascular stiffness <sup><xref rid="r28" ref-type="bibr">28</xref>,<xref rid="r29" ref-type="bibr">29</xref></sup>, has a direct interdependence with key hemodynamic factors, such as
stroke volume and peak aortic blood flow <sup><xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r30" ref-type="bibr">30</xref></sup>, and carries an
independent predictive power for the development of left ventricular dysfunction
<sup><xref rid="r31" ref-type="bibr">31</xref></sup> and CHF in previously healthy
subjects <sup><xref rid="r32" ref-type="bibr">32</xref></sup>. In addition, there is a
direct relationship between elevated PP and adverse outcome in patients with
asymptomatic LV dysfunction <sup><xref rid="r31" ref-type="bibr">31</xref></sup> and HF
<sup><xref rid="r33" ref-type="bibr">33</xref></sup>. </p><p>Aronson <sup><xref rid="r11" ref-type="bibr">11</xref></sup> in his study observed that
a lower PP in patients with decompensated HF determined greater risk of death. Also, he
concluded that PP depends on the patient's clinical setting, as a high PP in patients
with decompensated HF conferred preserved contractility and in outpatients, it confers a
higher risk of events. The patients in this study had been in NYHA class II and III for
at least 3 months without admission to the emergency room or hospital and therefore,
clinically stable.</p><p>Verdecchia et al <sup><xref rid="r14" ref-type="bibr">14</xref></sup> found a higher
risk for cardiovascular events when pulse pressure was greater than 53 mmHg. In this
study, patients showed an initial PP close to 50 mmHg and CPAP reduced this parameter
continuously, which persisted after the withdrawal of NIV.</p><p>The present study showed a PP decrease in patients with stable CHF submitted to NIV with
CPAP associated with other hemodynamic changes, both in the open study, as well as in
the double-blinded controlled cross-over protocol. The patients enrolled in the present
study had LVEF &#x02264;45% and high basal PP, which denotes left ventricular dysfunction and a
reduction in arterial compliance or distensibility, with an increase in vessel
stiffness. These results may have direct clinical implications, as the decrease in PP
produced by CPAP may represent improved left ventricular ejection and reduced adverse
outcomes. </p><p>In addition to the effects on PP, NIV with CPAP also caused a marked effect on other
hemodynamic and respiratory variables, which may reflect changes in autonomic modulation
rather than or in addition to ventricular loading and venous return <sup><xref rid="r34" ref-type="bibr">34</xref></sup>. The decreased respiratory rate might
reflect improved ventilation, explaining the subjective sensation of all the patients
who reported greater respiratory comfort. Regarding the hemodynamic variables, there are
a number of autonomic reflex links between the pulmonary and circulatory systems that
include reflex responses to changes in chest wall and/or respiratory mechanoreceptors,
and reflex responses to changes in arterial gas tensions <sup><xref rid="r35" ref-type="bibr">35</xref></sup>. Indeed, lung inflation can lead to systemic
vasodilatation via a vagal mediated reflex, which could result in decreases in cardiac
volume secondary to decreased LV afterload <sup><xref rid="r36" ref-type="bibr">36</xref></sup>. The blood pressure reduction observed under NIV could be
explained by increased airway and intrathoracic pressure leading to increased lung
volume and subsequent decreases in transmural left ventricular pressure and afterload
<sup><xref rid="r36" ref-type="bibr">36</xref></sup>. </p><p>NIV is a safe and feasible ventilation method easily applied in the ambulatory setting,
but its effectiveness is critically dependent on patient comfort and acceptance
<sup><xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r27" ref-type="bibr">27</xref></sup>. Therefore, in the present study, a preliminary NIV session
(phase 1) for adaptation and determination of the mask was performed. This preliminary
session was also employed to determine the individual CPAP pressure to be used in the
subsequent experiments, which was determined to be the lowest pressure that resulted in
greater hemodynamic responses, while being comfortable for the patient. The CPAP
pressure level that resulted in significant hemodynamic responses was close to 6
cmH<sub>2</sub>O. These values of CPAP pressure were similar to those in previous
studies that demonstrated improved cardiac output with low CPAP levels <sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r37" ref-type="bibr">37</xref></sup>. As previous publications had shown myocardial ischemia in patients
with ischemic heart failure during the administration of bilevel positive airway
pressure (Bipap)<sup><xref rid="r38" ref-type="bibr">38</xref>,<xref rid="r39" ref-type="bibr">39</xref></sup>, the CPAP mode was chosen in order to decrease the
occurrence of potential adverse outcomes. Accordingly, there were no events triggered by
CPAP in the patients participating in the present study. </p><sec><title>Limitations</title><p>In our study it was not possible to determine the exact mechanism responsible for the
hemodynamic changes; however, it is already known from previous studies that
increases in cardiac output with CPAP might be explained by systemic vasodilatation,
possibly on a reflex basis, leading to a decrease in the left ventricular afterload
and consequent increased stroke volume and cardiac output <sup><xref rid="r35" ref-type="bibr">35</xref></sup>. We observed that the hemodynamic effects of NIV with
CPAP remained up to five minutes after CPAP withdrawal; however, we understand that
further studies are needed to determine the duration of these effects after CPAP
cessation. Although in the present study clinic outcomes were not measured, in a
previous study an improvement was observed in the exercise tolerance with CHF
patients after NIV with CPAP (placebo vs. CPAP)<sup><xref rid="r40" ref-type="bibr">40</xref></sup>.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>We conclude that NIV with CPAP is an effective non-pharmacological method to reduce
pulse pressure in patients with stable chronic heart failure with potential clinical
implications for the management of this group of patients.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>
<bold>Potential Conflict of Interest</bold>
</p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="other"><p>
<bold>Study Association</bold>
</p><p>This article is part of the thesis of master submitted by M&#x000f4;nica Quint&#x000e3;o from
Universidade Federal Fluminense.</p></fn><fn fn-type="con"><p>
<bold>Author contributions</bold>
</p><p>Conception and design of the research: Quint&#x000e3;o M, Chermont S, Mesquita ET, N&#x000f3;brega
ACL; Acquisition of data: Quint&#x000e3;o M, Chermont S, Rocha NN; Analysis and
interpretation of the data: Quint&#x000e3;o M, Chermont S, Marchese L, Brand&#x000e3;o L, Bernardez
SP, Mesquita ET, Rocha NN, N&#x000f3;brega ACL; Statistical analysis: Quint&#x000e3;o M, Chermont S,
N&#x000f3;brega ACL; Writing of the manuscript: Quint&#x000e3;o M, Chermont S, Marchese L, Bernardez
SP, Mesquita ET, N&#x000f3;brega ACL; Critical revision of the manuscript for intellectual
content: Quint&#x000e3;o M, Chermont S, Marchese L, Brand&#x000e3;o L, Bernardez SP, Mesquita ET,
N&#x000f3;brega ACL.</p></fn><fn fn-type="financial-disclosure"><p>
<bold>Sources of Funding</bold>
</p><p>There were no external funding sources for this study.</p></fn></fn-group><ref-list><title>References </title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Auricchio</surname><given-names>A</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><etal>et al</etal></person-group><article-title>ESC Committee for Practice Guidelines. ESC guidelines for the
diagnosis and treatment of acute and chronic heart failure 2012: the Task Force
for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the
European Society of Cardiology. Developed in collaboration with the Heart Failure
Association (HFA) of the ESC</article-title><source>Eur J Heart Fail</source><year>2012</year><volume>14</volume><issue>8</issue><fpage>803</fpage><lpage>869</lpage><comment>Erratum in: Eur J Heart Fail. 2013;15(3):361-2.</comment><pub-id pub-id-type="pmid">22828712</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbur</surname><given-names>J</given-names></name><name><surname>James</surname><given-names>P</given-names></name></person-group><article-title>Diagnosis and management of heart failure in the outpatient
setting</article-title><source>Prim Care</source><year>2005</year><volume>32</volume><issue>4</issue><fpage>1115</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">16326230</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiopulos</surname><given-names>N</given-names></name><name><surname>Meister</surname><given-names>JJ</given-names></name><name><surname>Westerhof</surname><given-names>N</given-names></name></person-group><article-title>Determinants of stroke volume and systolic and diastolic aortic
pressure</article-title><source>Am J Physiol</source><year>1996</year><volume>270</volume><issue>6</issue><issue-part>Pt 2</issue-part><fpage>H2050</fpage><lpage>H2059</lpage><pub-id pub-id-type="pmid">8764256</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiopulos</surname><given-names>N</given-names></name><name><surname>Westerhof</surname><given-names>N</given-names></name></person-group><article-title>Determinants of pulse pressure</article-title><source>Hypertension</source><year>1998</year><volume>32</volume><issue>3</issue><fpage>556</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">9740625</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safar</surname><given-names>ME</given-names></name><name><surname>Levy</surname><given-names>BI</given-names></name><name><surname>Struijker-Boudier</surname><given-names>H</given-names></name></person-group><article-title>Current perspectives on arterial stiffness and pulse pressure in
hypertension and cardiovascular diseases</article-title><source>Circulation</source><year>2003</year><volume>107</volume><issue>22</issue><fpage>2864</fpage><lpage>2869</lpage><pub-id pub-id-type="pmid">12796414</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dart</surname><given-names>AM</given-names></name><name><surname>Kingwell</surname><given-names>BA</given-names></name></person-group><article-title>Pulse pressure - a review of mechanisms and clinical
relevance</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>37</volume><issue>4</issue><fpage>975</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">11263624</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milnor</surname><given-names>WR</given-names></name></person-group><article-title>Arterial impedance as ventricular afterload</article-title><source>Circ Res</source><year>1975</year><volume>36</volume><issue>5</issue><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">1122568</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>RP</given-names></name><name><surname>Tunin</surname><given-names>R</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name></person-group><article-title>Effect of reduced aortic compliance on cardiac efficiency and
contractile function of in situ canine left ventricle</article-title><source>Circ Res</source><year>1992</year><volume>71</volume><issue>3</issue><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">1386792</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>F</given-names></name><name><surname>Kumada</surname><given-names>T</given-names></name><name><surname>Kambayashi</surname><given-names>M</given-names></name><name><surname>Hayashida</surname><given-names>W</given-names></name><name><surname>Ishikawa</surname><given-names>N</given-names></name><name><surname>Sasayama</surname><given-names>S</given-names></name></person-group><article-title>Change in aortic end-systolic pressure by alterations in loading
sequence and its relation to left ventricular isovolumic
relaxation</article-title><source>Circulation</source><year>1996</year><volume>93</volume><issue>11</issue><fpage>2080</fpage><lpage>2087</lpage><pub-id pub-id-type="pmid">8640985</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kass</surname><given-names>DA</given-names></name><name><surname>Saeki</surname><given-names>A</given-names></name><name><surname>Tunin</surname><given-names>RS</given-names></name><name><surname>Recchia</surname><given-names>FA</given-names></name></person-group><article-title>Adverse influence of systemic vascular stiffening on cardiac
dysfunction and adaptation to acute coronary occlusion</article-title><source>Circulation</source><year>1996</year><volume>93</volume><issue>8</issue><fpage>1533</fpage><lpage>1541</lpage><pub-id pub-id-type="pmid">8608622</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronson</surname><given-names>D</given-names></name><name><surname>Burger</surname><given-names>AJ</given-names></name></person-group><article-title>Relation between pulse pressure and survival in patients with
decompensated heart failure</article-title><source>Am J Cardiol</source><year>2004</year><volume>93</volume><issue>6</issue><fpage>785</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">15019896</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TT</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>DJ</given-names></name><name><surname>Tsao</surname><given-names>L</given-names></name></person-group><article-title>The association between blood pressure and mortality in patients with
heart failure</article-title><source>Am Heart J</source><year>2006</year><volume>151</volume><issue>1</issue><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">16368295</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Vol</surname><given-names>S</given-names></name><name><surname>Brisac</surname><given-names>AM</given-names></name><name><surname>Tichet</surname><given-names>J</given-names></name><name><surname>Topouchian</surname><given-names>J</given-names></name></person-group><article-title>Reference values for clinic pulse pressure in a nonselected
population</article-title><source>Am J Hypertens</source><year>2001</year><volume>14</volume><issue>5</issue><issue-part>Pt 1</issue-part><fpage>415</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">11368460</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdecchia</surname><given-names>P</given-names></name><name><surname>Schillaci</surname><given-names>G</given-names></name><name><surname>Borgioni</surname><given-names>C</given-names></name><name><surname>Ciucci</surname><given-names>A</given-names></name><name><surname>Pede</surname><given-names>S</given-names></name><name><surname>Porcellati</surname><given-names>C</given-names></name></person-group><article-title>Ambulatory pulse pressure: a potent predictor of total cardiovascular
risk in hypertension</article-title><source>Hypertension</source><year>1998</year><volume>32</volume><issue>6</issue><fpage>983</fpage><lpage>988</lpage><pub-id pub-id-type="pmid">9856961</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Sociedade Brasileira de Cardiologia</collab><collab>Sociedade Brasileira de Hipertens&#x000e3;o</collab><collab>Sociedade Brasileira de Nefrologia</collab></person-group><article-title xml:lang="pt">V Diretrizes Brasileiras de Monitoriza&#x000e7;&#x000e3;o Ambulatorial
da Press&#x000e3;o Arterial (MAPA) e III Diretrizes Brasileiras de Monitoriza&#x000e7;&#x000e3;o
Residencial de Press&#x000e3;o Arterial (MRPA)</article-title><source>Arq Bras Cardiol</source><year>2011</year><volume>97</volume><issue>3</issue><supplement>supl.3</supplement><fpage>1</fpage><lpage>24</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>NS</given-names></name></person-group><article-title>Noninvasive ventilation</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>540</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">11179136</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>RL</given-names></name><name><surname>Feller</surname><given-names>ED</given-names></name><name><surname>Gottlieb</surname><given-names>SS</given-names></name></person-group><article-title>Acute congestive heart failure in the emergency
department</article-title><source>Cardiol Clin</source><year>2006</year><volume>24</volume><issue>1</issue><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">16326261</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naughton</surname><given-names>MT</given-names></name><name><surname>Rahman</surname><given-names>MA</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Floras</surname><given-names>JS</given-names></name><name><surname>Bradley</surname><given-names>TD</given-names></name></person-group><article-title>Effect of continuous positive airway pressure in intrathoracic and
left ventricular transmural pressures in patients with congestive heart
failure</article-title><source>Circulation</source><year>1995</year><volume>91</volume><issue>6</issue><fpage>1725</fpage><lpage>1731</lpage><pub-id pub-id-type="pmid">7882480</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>TD</given-names></name><name><surname>Holloway</surname><given-names>RM</given-names></name><name><surname>McLaughlin</surname><given-names>PR</given-names></name><name><surname>Ross</surname><given-names>BL</given-names></name><name><surname>Walters</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name></person-group><article-title>Cardiac output response to continuous positive airway pressure in
congestive heart failure</article-title><source>Am Rev Respir Dis</source><year>1992</year><volume>145</volume><issue>2</issue><issue-part>Pt 1</issue-part><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">1736745</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Hoyos</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Benard</surname><given-names>DC</given-names></name><name><surname>Bradley</surname><given-names>TD</given-names></name></person-group><article-title>Hemodynamic effects of continuous positive airway pressure in humans
with normal and impaired left ventricular function</article-title><source>Clin Sci (Lond)</source><year>1995</year><volume>88</volume><issue>2</issue><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">7720341</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendjelid</surname><given-names>K</given-names></name><name><surname>Sch&#x000fc;tz</surname><given-names>N</given-names></name><name><surname>Suter</surname><given-names>PM</given-names></name><name><surname>Fournier</surname><given-names>G</given-names></name><name><surname>Jacques</surname><given-names>D</given-names></name><name><surname>Fareh</surname><given-names>S</given-names></name><etal>et al</etal></person-group><article-title>Does continuous positive airway pressure by face mask improve patients
with acute cardiogenic pulmonary edema due to left ventricular diastolic
dysfunction?</article-title><source>Chest</source><year>2005</year><volume>127</volume><issue>3</issue><fpage>1053</fpage><lpage>1058</lpage><pub-id pub-id-type="pmid">15764794</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinsky</surname><given-names>MR</given-names></name></person-group><article-title>Cardiovascular issues in respiratory care</article-title><source>Chest</source><year>2005</year><volume>128</volume><issue>5</issue><supplement>Suppl 2</supplement><fpage>592S</fpage><lpage>597S</lpage><pub-id pub-id-type="pmid">16306058</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zieman</surname><given-names>SJ</given-names></name><name><surname>Melenovsky</surname><given-names>V</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name></person-group><article-title>Mechanisms, pathophysiology, and therapy of arterial
stiffness</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><issue>5</issue><fpage>932</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">15731494</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>GM</given-names></name><name><surname>Marchais</surname><given-names>SJ</given-names></name><name><surname>Guerin</surname><given-names>AP</given-names></name><name><surname>Pannier</surname><given-names>B</given-names></name></person-group><article-title>Arterial stiffness: pathophysiology and clinical
impact</article-title><source>Clin Exp Hypertens</source><year>2004</year><volume>26</volume><issue>7-8</issue><fpage>689</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">15702623</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadar</surname><given-names>S</given-names></name><name><surname>Prasad</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Lip</surname><given-names>GY</given-names></name></person-group><article-title>Positive pressure ventilation in the management of acute and chronic
cardiac failure: a systematic review and meta-analysis</article-title><source>Int J Cardiol</source><year>2005</year><volume>99</volume><issue>2</issue><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">15749172</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baratz</surname><given-names>DM</given-names></name><name><surname>Westbrook</surname><given-names>PR</given-names></name><name><surname>Shah</surname><given-names>PK</given-names></name><name><surname>Mohsenifar</surname><given-names>Z</given-names></name></person-group><article-title>Effect of nasal continuous positive airway pressure on cardiac output
and oxygen delivery in patients with congestive heart failure</article-title><source>Chest</source><year>1992</year><volume>102</volume><issue>5</issue><fpage>1397</fpage><lpage>1401</lpage><pub-id pub-id-type="pmid">1424858</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bersten</surname><given-names>AD</given-names></name><name><surname>Holt</surname><given-names>AW</given-names></name><name><surname>Vedig</surname><given-names>AE</given-names></name><name><surname>Skowronki</surname><given-names>GA</given-names></name><name><surname>Baggoley</surname><given-names>CJ</given-names></name></person-group><article-title>Treatment of severe cardiogenic pulmonary edema with continuous
positive airway pressure delivered by face mask</article-title><source>N Engl J Med</source><year>1991</year><volume>325</volume><issue>26</issue><fpage>1825</fpage><lpage>1830</lpage><pub-id pub-id-type="pmid">1961221</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dart</surname><given-names>AM</given-names></name><name><surname>Kingwell</surname><given-names>BA</given-names></name></person-group><article-title>Pulse pressure-a review of mechanisms and clinical
relevance</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>37</volume><issue>4</issue><fpage>975</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">11263624</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domanski</surname><given-names>MJ</given-names></name><name><surname>Davis</surname><given-names>BR</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Kastantin</surname><given-names>M</given-names></name><name><surname>Mitchell</surname><given-names>GF</given-names></name></person-group><article-title>Isolated systolic hypertension prognostic information provided by
pulse pressure</article-title><source>Hypertension</source><year>1999</year><volume>34</volume><issue>3</issue><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">10489379</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milnor</surname><given-names>WR</given-names></name></person-group><article-title>Arterial impedance as ventricular afterload</article-title><source>Circ Res</source><year>1975</year><volume>36</volume><issue>5</issue><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">1122568</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Moy&#x000e9;</surname><given-names>LA</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Rouleau</surname><given-names>JL</given-names></name><name><surname>Bernstein</surname><given-names>V</given-names></name><name><surname>Geltman</surname><given-names>EM</given-names></name><etal>et al</etal></person-group><article-title>Sphygmomanometric determined pulse pressure is a powerful independent
predictor of recurrent events after myocardial infarction in patients with
impaired left ventricular function. SAVE investigators. Survival and Ventricular
Enlargement</article-title><source>Circulation</source><year>1997</year><volume>96</volume><issue>12</issue><fpage>4254</fpage><lpage>4260</lpage><pub-id pub-id-type="pmid">9416890</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>CU</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Glynn</surname><given-names>RJ</given-names></name><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><article-title>Increased pulse pressure and risk of heart failure in the
elderly</article-title><source>JAMA</source><year>1999</year><volume>281</volume><issue>7</issue><fpage>634</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">10029125</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domanski</surname><given-names>MJ</given-names></name><name><surname>Mitchell</surname><given-names>GF</given-names></name><name><surname>Norman</surname><given-names>JE</given-names></name><name><surname>Exner</surname><given-names>DV</given-names></name><name><surname>Pitt</surname><given-names>B</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name></person-group><article-title>Independent prognostic information provided by sphygmomanometrically
determined pulse pressure and mean arterial pressure in patients with left
ventricular dysfunction</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>33</volume><issue>4</issue><fpage>951</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">10091821</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname><given-names>DM</given-names></name><name><surname>Mansfield</surname><given-names>D</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Naugthton</surname><given-names>MT</given-names></name><name><surname>Esler</surname><given-names>MD</given-names></name></person-group><article-title>Acute effects of continuous positive airway pressure on cardiac
sympathetic tone in congestive heart failure</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>19</issue><fpage>2336</fpage><lpage>2338</lpage><pub-id pub-id-type="pmid">11352880</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>SM</given-names></name></person-group><source>Respiratory-circulatory interactions in health and disease: lung biology in
health and disease</source><publisher-loc> New York</publisher-loc><publisher-name>NY: Marcel Dekker</publisher-name><year>2001</year><fpage>519</fpage><lpage>549</lpage></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pinsky</surname><given-names>MR</given-names></name></person-group><source>Heart-lung interactions in health and disease: lung biology in health and
disease</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Marcel Dekker</publisher-name><year>1989</year><fpage>839</fpage><lpage>876</lpage></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pery</surname><given-names>M</given-names></name><name><surname>Payen</surname><given-names>D</given-names></name><name><surname>Pinsky</surname><given-names>MR</given-names></name></person-group><article-title>Monitoring the effect of CPAP on left ventricular function using
continuous blood saturation</article-title><source>Chest</source><year>1991</year><volume>99</volume><issue>2</issue><fpage>512</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">1824930</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>S</given-names></name><name><surname>Jay</surname><given-names>GD</given-names></name><name><surname>Woolard</surname><given-names>RH</given-names></name><name><surname>Hipona</surname><given-names>RA</given-names></name><name><surname>Connolly</surname><given-names>EM</given-names></name><name><surname>Cimini</surname><given-names>DM</given-names></name><etal>et al</etal></person-group><article-title>Randomized, prospective trial of bilevel versus continuous positive
airway pressure in acute pulmonary edema</article-title><source>Crit Care Med</source><year>1997</year><volume>25</volume><issue>4</issue><fpage>620</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">9142026</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellone</surname><given-names>A</given-names></name><name><surname>Monari</surname><given-names>A</given-names></name><name><surname>Cortellaro</surname><given-names>F</given-names></name><name><surname>Vettorello</surname><given-names>M</given-names></name><name><surname>Arlati</surname><given-names>S</given-names></name><name><surname>Coen</surname><given-names>D</given-names></name></person-group><article-title>Myocardial infarction rate in acute pulmonary edema: noninvasive
pressure support ventilation versus continuous positive airway
pressure</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><issue>9</issue><fpage>1860</fpage><lpage>1865</lpage><pub-id pub-id-type="pmid">15343013</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chermont</surname><given-names>S</given-names></name><name><surname>Quint&#x000e3;o</surname><given-names>MM</given-names></name><name><surname>Mesquita</surname><given-names>ET</given-names></name><name><surname>Rocha</surname><given-names>NN</given-names></name><name><surname>N&#x000f3;brega</surname><given-names>AC</given-names></name></person-group><article-title>Non-invasive ventilation with continuous positive airway pressure
acutely improves 6-minute walk distance in chronic heart failure</article-title><source>J Cardiopulm Rehabil Prev</source><year>2009</year><volume>29</volume><issue>1</issue><fpage>44</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">19158587</pub-id></element-citation></ref></ref-list></back></article>